FITC anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_FITC_021606
C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) FITC and CD127 (clone SB/199) PE.
  • 145-2C11_FITC_021606
    C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) FITC and CD127 (clone SB/199) PE.
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100305 50 µg £21
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100306 500 µg £68
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Chei S, et al. 2020. Front Nutr. 7:583186. PubMed
  2. Bertrand F, et al. 2017. Nat Commun. 8:2256. PubMed
  3. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  4. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  5. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  6. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  7. Schulteis R, et al. 2008. Blood. 112:4905. PubMed
  8. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  9. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  10. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  11. Fornari T, et al. 2015. PLoS One. 10: 0142688. PubMed
  12. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  13. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  14. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  15. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  16. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  17. Allegrezza M, et al. 2016. Cancer Res . 76: 6253 - 6265. PubMed
  18. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  19. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  20. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  21. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  22. Lou F, et al. 2020. STAR Protoc. 1:100115. PubMed
  23. Patnode M, et al. 2013. Glycobiology. 23:381. PubMed
  24. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  25. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  26. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  27. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  28. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  29. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  30. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  31. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  32. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  33. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  34. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  35. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  36. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  37. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  38. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  39. Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed
  40. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  41. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  42. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  43. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  44. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  45. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  46. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  47. Skeate JG, et al. 2018. PLoS One. 13:e0191311. PubMed
  48. He L, et al. 2019. iScience. 0.790972222. PubMed
  49. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  50. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  51. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  52. Miki Y, et al. 2016. J Biol Chem. 291: 15588 - 15601. PubMed
  53. Tang CC, et al. 2021. eLife. 10:00. PubMed
  54. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  55. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  56. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  57. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  58. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  59. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  60. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  61. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  62. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  63. Yang H, et al. 2022. Nutrients. 14:. PubMed
  64. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  65. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  66. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  67. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  68. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  69. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  70. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  71. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  72. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  73. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  74. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  75. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  76. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  77. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  78. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  79. Bian G, et al. 2020. British Journal of Pharmacology. 178(3):636-653. PubMed
  80. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  81. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  82. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  83. Kim MY, et al. 2017. Plant Biotechnol J. 1.729166667. PubMed
  84. Xu M, et al. 2013. J Immunol. 190:5436. PubMed
  85. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  86. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  87. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  88. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  89. Labiano S, et al. 2017. Oncoimmunology. 6:e1283468. PubMed
  90. Engblom C, et al. 2017. Science. 358:6367. PubMed
  91. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  92. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  93. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  94. Yue W, et al. 2019. Nat Commun. 10:2025. PubMed
  95. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  96. Lind L, et al. 2021. J Neurovirol. 27:145. PubMed
  97. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  98. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  99. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  100. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  101. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  102. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  103. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  104. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  105. Lin JC, et al. 2019. Nat Commun. 10:1057. PubMed
  106. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  107. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  108. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  109. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  110. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  111. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  112. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  113. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  114. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  115. Sheng J, et al. 2021. eLife. 10:00. PubMed
  116. Nakagawa Y, et al. 2015. Immunol Lett. 167: 72-86. PubMed
  117. Ikeda T, et al. 2014. PLoS One. 9:115198. PubMed
  118. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  119. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  120. Schofield L, et al. 2017. BMC Med. 10.1186/s12916-017-0883-8. PubMed
  121. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  122. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  123. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  124. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  125. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  126. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  127. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  128. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  129. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  130. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  131. Kanaya T, et al. 2008. Am J Physiol Gastrointest Liver Physiol. 295:273. PubMed
  132. Zhou X, et al. 2021. Nutr Metab (Lond). 18:64. PubMed
  133. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  134. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  135. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  136. Amatruda M, et al. 2022. Brain Commun. 4:fcac044. PubMed
  137. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
RRID
AB_312670 (BioLegend Cat. No. 100305)
AB_312671 (BioLegend Cat. No. 100306)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD3ε

  • Biotin anti-mouse CD3ε

  • FITC anti-mouse CD3ε

  • PE anti-mouse CD3ε

  • PE/Cyanine5 anti-mouse CD3ε

  • Purified anti-mouse CD3ε

  • PE/Cyanine7 anti-mouse CD3ε

  • Alexa Fluor® 488 anti-mouse CD3ε

  • Alexa Fluor® 647 anti-mouse CD3ε

  • PerCP anti-mouse CD3ε

  • PerCP/Cyanine5.5 anti-mouse CD3ε

  • Purified anti-mouse CD3ε (Maxpar® Ready)

  • APC/Cyanine7 anti-mouse CD3ε

  • Pacific Blue™ anti-mouse CD3ε

  • Brilliant Violet 421™ anti-mouse CD3ε

  • Ultra-LEAF™ Purified anti-mouse CD3ε

  • PE/Dazzle™ 594 anti-mouse CD3ε

  • Brilliant Violet 510™ anti-mouse CD3ε

  • Brilliant Violet 605™ anti-mouse CD3ε

  • Brilliant Violet 711™ anti-mouse CD3ε

  • Brilliant Violet 785™ anti-mouse CD3ε

  • APC/Fire™ 750 anti-mouse CD3ε

  • GoInVivo™ Purified anti-mouse CD3ε

  • Spark YG™ 593 anti-mouse CD3

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account